Passam F, Rahgozar S, et al. Current concepts on the pathogenesis of the antiphospholipid syndrome[J]. Blood, 2007, 109(2):422430.
[4] Zhang J, McCrae KR. Annexin A2 mediates endothelial cell activation by antiphospholipid/antibeta2 glycoprotein I antibodies[J].Blood,2005,105(5):19641969.
[5] Meroni PL,Raschi E,Testoni C,et al. Statins prevent endothelial cell activation induced by antiphospholipid (antibeta2glycoprotein I) antibodies: effect on the proadhesive and proinflammatory phenotype[J].Arthritis Rheum,2001,44(12): 28702878.
[6] Jaber J, Murin J, Kinova S, et al. The role of infection and inflammation in the pathogenesis of atherosclerosis[J]. Vnitr Lek, 2002, 48(7):657666.
[7] Nicolo D, Varadhachary AS, Monestier M. Atherosclerosis,antiphospholipid syndrome and antiphospholipid antibodies[J]. Front Biosci,2007,12(1):21712182.
[8] 王瑞,王娟.他汀类药物非调脂作用的研究进展[J].承德医学院学报,2009,26(1):7779.
[9] 鲍晓,关永源.他汀类药物对心血管的保护作用[J]. 中国药理学通报,2005,21(11):12891292.
[10]吉宁飞,吉佑华,吉卫华,等.阿托伐他汀对高脂血症者高敏C反应蛋白的影响及其调脂疗效和安全性评估[J].实用老年医学,2009,23(1):1922.
[11]Calabrò P,Yeh ET. The pleiotropic effects of statins[J]. Curr Opin Cariol,2005,20(6):541546.
[12]Jajoria P, Murthy V, Papalardo E,et al. Statins for the treatment of antiphospholipid syndrome?[J].Ann N Y Acad Sci,2009,1173:736745.
[13]袁云波,任海赢,周红坚.阿托伐他汀治疗老年人颈动脉粥样斑块临床观察[J].现代诊断与治疗,2009,20(1):2122.
仁和医学论文网专业提供代写代发医学论文服务,并提供大量论文资料,如有业务需求请咨询网站客服人员!
上一页 [1] [2] [3] [4]